ArticleHepatology international2018

Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan.

Fumitaka Suzuki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.